However, the underutilization of GLP-1 RAs represents a significant opportunity to improve post-transplant outcomes in this high-risk population
The submission is supported by the SURPASS CVOT trial, which showed that Mounjaro reduced the risk of MACE including cardiovascular (CV) death, heart attack, or stroke by 8% compared with dulaglutide (Trulicity
At the 12mg dose, Phase 2 participants averaged about 24 percent body weight loss over 48 weeks, and the larger Phase 3 TRIUMPH-4 trial reported close to 29 percent at 68 weeks, an average of roughly 71 pounds
With InsideTracker, youll be able to: Verify whether your metabolism and heart health are improving Monitor changes to your gut health, so you can resolve problems early Track hormonal changes that may affect how you feel Identify opportunities for better fitness, endurance, and muscle recoveryall all of which will make exercise easier Receive personalized recommendations for optimizing any blood biomarkers that are outside the ideal range Click to learn more about GLP-1 biomarker testing with InsideTracker
Diabetes, Obesity Metab
Constipation Some researchers experience the opposite problem